Accès gratuit
Med Sci (Paris)
Volume 25, Numéro 5, Mai 2009
Évaluation des risques et perspectives thérapeutiques en oncologie colorectale
Page(s) 473 - 482
Section M/S revues
Publié en ligne 15 mai 2009
  1. Masuoka J. Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev 2004; 17 : 281–310.
  2. Netea MG, Brown GD, Kullberg BJ, Gow NA. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 2008; 6 : 67–78.
  3. Latge JP. The cell wall: a carbohydrate armour for the fungal cell. Mol Microbiol 2007; 66 : 279–90.
  4. Biguet J, Tran van Ky P, Andrieu S, Fruit J. Immunoelectrophoretic analysis of fungal antigens and systematic analysis of fungi. Practical repercussions on the diagnosis of mycoses. Mycopathol Mycol Appl 1965; 26 : 241–56.
  5. Martinez JP, Gil ML, Lopez-Ribot JL, Chaffin WL. Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin Microbiol Rev 1998; 11 : 121–41.
  6. Pitarch A, Jimenez A, Nombela C, Gil C. Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses. Mol Cell Proteomics 2006; 5 : 79–96.
  7. Dumas FR, Bougnoux ME, Zahar JR, Lortholary O. Candidiasis emerging species under antibiotic treatment: clinical impact. Med Sci (Paris) 2008; 24 : 24–31.
  8. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20 : 133–63.
  9. Loftus EV, Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterol 2004; 126 : 1504–17.
  10. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134 : 577–94.
  11. Li X, Conklin L, Alex P. New serological biomarkers of inflammatory bowel disease. World J Gastroenterol 2008; 14 : 5115–24.
  12. Biswas S, Van Dijck P, Datta A. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 2007; 71 : 348–76.
  13. Suzuki S. Immunochemical study on mannans of genus Candida. I. Structural investigation of antigenic factors 1, 4, 5, 6, 8, 9, 11, 13, 13b and 34. Curr Top Med Mycol 1997; 8 : 57–70.
  14. Trinel PA, Maes E, Zanetta JP, et al. Candida albicans phospholipomannan, a new member of the fungal mannose inositol phosphoceramide family. J Biol Chem 2002; 277 : 37260–71.
  15. Jouault T, Ibata-Ombetta S, Takeuchi O, et al. Candida albicans phospholipomannan is sensed through toll-like receptors. J Infect Dis 2003; 188 : 165–72.
  16. Fradin C, Slomianny MC, Mille C, et al. Beta-1,2 oligomannose adhesin epitopes are widely distributed over the different families of Candida albicans cell wall mannoproteins and are associated through both N- and O-glycosylation processes. Infect Immun 2008; 76 : 4509–17.
  17. Mille C, Bobrowicz P, Trinel PA, et al. Identification of a new family of genes involved in beta-1,2-mannosylation of glycans in Pichia pastoris and Candida albicans. J Biol Chem 2008; 283 : 9724–36.
  18. Sendid B, Tabouret M, Poirot JL, et al. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999; 37 : 1510–7.
  19. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220 : 751–8.
  20. Sendid B, Jouault T, Coudriau R, et al. Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis. J Clin Microbiol 2004; 42 : 164–71.
  21. Poulain D, Faille C, Michalski JC, Camus D. Monoclonal antibodies to Candida albicans- from cell biology to diagnostic probes. Med Sci (Paris) 1990; 6 : 526–33.
  22. Prella M, Bille J, Pugnale M, et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005; 51 : 95–101.
  23. Collot M, Sendid B, Fievez A, et al. Biotin sulfone as a new tool for synthetic oligosaccharide immobilization: application to multiple analysis profiling and surface plasmonic analysis of anti-Candida albicans antibody reactivity against alpha and beta (1 → 2) oligomannosides. J Med Chem 2008; 51 : 6201–10.
  24. Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (bakers’ yeast) in Crohn’s disease. BMJ 1988; 297 : 1105–6.
  25. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42 : 788–91.
  26. Sendid B, Colombel JF, Jacquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn’s disease. Clin Diagn Lab Immunol 1996; 3 : 219–26.
  27. Poulain D, Sendid B, Fajardy I, Danze PM, Colombel JF. Mother to child transmission of anti-S cerevisiae mannan antibodies (ASCA) in non-IBD families. Gut 2000; 47 : 870–1.
  28. Sendid B, Quinton JF, Charrier G, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn’s disease. Am J Gastroenterol 1998; 93 : 1306–10.
  29. Israeli E, Grotto I, Gilburd B, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005; 54 : 1232–6.
  30. Vandewalle-El Khoury P, Colombel JF, Joossens S, et al. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn’s disease patients and contributes to differential diagnosis, stratification, and prediction. Am J Gastroenterol 2008; 103 : 949–57.
  31. Hadrich I, Vandewalle P, Cheikhrouhou F, et al. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn’s disease patients, their relatives or associated clinical factors. Scand J Gastroenterol 2007; 42 : 717–25.
  32. Standaert-Vitse A, Jouault T, Vandewalle P, et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn’s disease. Gastroenterol 2006; 130 : 1764–75.
  33. Jawhara S, Thuru X, Standaert-Vitse A, et al. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis 2008; 197 : 972–80.
  34. Standaert-Vitse A, Sendid B, Joossens M, et al. Candida albicans colonization and ASCA in familial Crohn’s disease. Am J Gastroenterol 2009 (sous presse).
  35. Dotan I, Fishman S, Dgani Y, et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn’s disease. Gastroenterol 2006; 131 : 366–78.
  36. Sendid B, Dotan N, Nseir S, et al. Antibodies against glucan, chitin and Saccharomyces cerevisiae mannan are new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan. Clin Vaccine Immunol 2008.
  37. Torosantucci A, Bromuro C, Chiani P, et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 2005; 202 : 597–606.
  38. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1 →3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41 : 654–9.
  39. Chiba M, Mikami K, Iizuka M, et al. Elevated plasma (1 →3)-beta-D-glucan, a fungal cell wall constituent, in a subgroup of Crohn disease. Scand J Gastroenterol 2001; 36 : 447–8.
  40. Leung-Theung-Long S, Guerder S. Th17 cells, a novel proinflammatory effector CD4 T cell population. Med Sci (Paris) 2009; 24 : 972–6.
  41. McGovern D, Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD. Gut 2007; 56 : 1333–6.
  42. Palm NW, Medzhitov R. Antifungal defense turns 17. Nat Immunol 2007; 8 : 549–51.
  43. Dupont B. Candidose hépatosplénique : un nouveau syndrome inflammatoire de reconstitution immunitaire ? J Mycol Méd 2007; 17 : 155–6.
  44. Seibold F, Boldt AB, Seibold-Schmid B, et al. Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn’s disease: a family study. Inflamm Bowel Dis 2007; 13 : 1077–82.
  45. van Till JW, Modderman PW, de Boer M, et al. Mannose-binding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis. Clin Vaccine Immunol 2008; 15 : 65–70.
  46. Jouault T, El Abed-El Behi M, Martinez-Esparza M, et al. Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 2006; 177 : 4679–87.
  47. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 2003; 41 : 90–6.
  48. Clancy CJ, Nguyen ML, Cheng S, et al. Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis. J Clin Microbiol 2008; 46 : 1647–54.
  49. Xin H, Dziadek S, Bundle DR, Cutler JE. Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci USA. 2008; 105 : 13526–31.
  50. Shibata N, Suzuki A, Kobayashi H, Okawa Y. Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms. Biochem J 2007; 404 : 365–72.
  51. Smits GJ, Kapteyn JC, van den Ende H, Klis FM. Cell wall dynamics in yeast. Curr Opin Microbiol 1999; 2 : 348–52.
  52. Peyrin-Biroulet L, Parmentier-Decrucq E, Branche J, Desreumaux P. IL-23R, a novel susceptibility gene for inflammatory bowel disease. Med Sci (Paris) 2007; 23 : 250–2.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.